Overview

Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known which combination chemotherapy regimen is more effective for cancer of unknown primary origin. PURPOSE: Randomized phase III trial to compare the effectiveness of two different regimens of combination chemotherapy in treating patients with cancer of unknown primary origin.
Phase:
Phase 3
Details
Lead Sponsor:
Academisch Ziekenhuis Maastricht
Treatments:
Albumin-Bound Paclitaxel
Calcium
Carboplatin
Etoposide
Etoposide phosphate
Fluorouracil
Leucovorin
Levoleucovorin
Paclitaxel